Infusion Pump Market - Forecast(2024 - 2030)

Report Code: HCR 49498 Report Format: PDF + Excel
Infusion Pump Market Overview
Infusion Pump Market size is estimated to be $7.6 billion in 2019, growing at a CAGR of 5.6% during the forecast period 2020-2025. Rising population along with growing chronic disorders like diabetes among adults and technological advancement is a major factor driving the Infusion Pump Market during the forecast period 2020-2025. An infusion pump is a medical device that delivers fluid such as nutrients and medication into the patient’s body, in a controlled amount. Moreover, insulin pump offers several advantages over manual administration of fluids, including the ability to deliver fluids in very small volumes, and the ability to deliver fluids at precisely at programmed rates or automated intervals. Furthermore, the ability to deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers to the human body is further driving its market growth. Also, the use of large volume pumps usually a peristaltic pump for fluid replacement using intravenously into the patient's circulatory system and the use of a flow restrictor to set the flow of drugs is further contributing to its market growth.

Report Coverage
The report: “Infusion Pump Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Infusion Pump Market.

By Product: Infusion Pumps, Accessories/Consumables
By End-Use: Hospitals, Ambulatory Surgery Centers, Home Care, and Others
By Application: Hematological Disorders, Cancer, Gastroenterological Disorders, Analgesia/Pain Management, Diabetes, and Pediatrics/Neonatal Disorders
By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Key Takeaways
  • North America dominated the Digital Therapeutics Market in 2019 owing to the presence of major players such as Becton and Dickinson in that region.
  • The growing number of patients treated in hospitals, the availability of qualified doctors to operate the infusion pump, and the financial ability of hospitals to buy high-priced infusion devices are contributing to the Infusion Pump Market growth.
  • Increased incidence of chronic diseases such as diabetes and other cardiovascular diseases is a major factor driving the Infusion Pump Market during the forecast period 2020-2025.

By Application- Segment Analysis 
Diabetes is set to be the fastest-growing segment during the forecast period 2020-2025 with a CAGR of 3.8%. This is owing to the increase in the number of diabetes patients around the world and to adopt different types of an insulin pumps. Rapid urbanization, changing lifestyles, and eating habits leading to diabetes are further contributing to its market growth. Moreover, according to the World Health Organization (WHO), the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. An insulin pump is a small device that mimics some of the ways a healthy pancreas works. It delivers continuous and customized doses of rapid-acting insulin 24 hours a day to match body needs. Technological advancement along with growing innovation leading to a wearable, small, and durable infusion pumps thus further driving its market growth.

By End-Use- Segment Analysis
By End-Use, Hospitals accounted for the largest market share in 2019 owing to benefits to provide different types of infusion pumps to patients. Also, infusion pumps are in widespread use in clinical settings such as hospitals, nursing homes, and in-home. Furthermore, the growing number of patients treated in hospitals, the availability of qualified doctors to operate the infusion pump and the financial ability of hospitals to buy high-priced infusion devices are driving the Infusion Pump Market during the forecast period 2020-2025.

Geography- Segment Analysis
North America dominated the Infusion Pump Market with a region share 36% in 2019. The rising geriatric population along with the increasing chronic disorder, growing demand for advanced technologies, adoption of an appropriate infusion pump, and the presence of large hospitals in that region is driving its market growth. Furthermore, the presence of major players such as Becton and Dickinson in that region is contributing to its market growth.

Drivers –Infusion Pump Market
  • Increasing incidence of chronic diseases
The increasing incidence of chronic diseases leading to diabetes and other cardiovascular diseases is a major driving the Infusion Pump Market during the forecast period 2020-2025. Furthermore, the growing diabetes patients and their  to adapt to different types of insulin pumps are driving the demand of Infusion Pump Market during the forecast period 2020-2025.

  • Rising Demand of Ambulatory Infusion Pump
The rising demand for ambulatory infusion pumps to deliver medicines like chemotherapy or antibiotics in the body is contributing to its market growth. The pump gives medication over a specific time frame as set by the doctor. Getting medication through ambulatory infusion pumps is advantageous, as people can carry out their daily activities at home without staying in the hospital overnight.

Challenges – Infusion Pump Market
  • Stringent Government Regulation
Stringent Government Regulation for new device approval is a major factor restraining the Infusion Pump Market during the forecast period 2020-2025. Moreover, the U.S. Food and Drugs Administration wrote a letter to the infusion pump manufacturers describing the problems related to it and asked additional assessments of new products or change the products that have been marketed. This serves as a setback for the growth of Infusion Pump Market.

Infusion Pump Market Industry Outlook 
Infusion Pump Market top 10 companies are B. Braun Melsungen AG, Baxter International Inc, Fresenius Se & Co. KGAA, Hospira Inc, Johnson & Johnson, Medtronic PLC, Moog Inc, Smiths Medical, Terumo Corporation and Roche Diagnostics.

Developments:
  • September 2019: Baxter acquired Cheetah Medical the developer of noninvasive fluid management monitoring system called the Starling SV for up to $230million. 

1. Infusion Pump Market Overview
    1.1 Definitions and Scope
2. Infusion Pump Market - Executive Summary
    2.1 Market Revenue and Key Trends 
    2.2 Key trends by Product
    2.3 Key trends by End-Use
    2.4 Key trends by Application
    2.5 Key trends by Geography
3. Infusion Pump Market –Comparative Analysis
    3.1 Product Benchmarking - Key companies
    3.2 Financials Analysis - Key Companies
    3.3 Market Share Analysis- Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Infusion Pump Market - Startup companies Scenario Premium (Premium) 
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Infusion Pump Market – Industry Market Entry Scenario Premium (Premium) 
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
        5.3 Case Studies of Successful Ventures
6. Infusion Pump Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Infusion Pump Market -Strategic analysis
    7.1 Value chain analysis 
    7.2 Opportunities analysis
    7.3 Market life cycle
8. Infusion Pump Market – By Product (Market Size –$Million/$Billion)
    8.1 Infusion Pumps
        8.1.1 Volumetric Infusion Pumps
        8.1.2 Syringe Infusion Pumps
        8.1.3 Ambulatory Infusion Pumps
            8.1.3.1 Disposable Infusion Pumps
            8.1.3.2 Chemotherapy Pumps
            8.1.3.3 Enteral Infusion Pumps
            8.1.3.4 Insulin Infusion Pumps
            8.1.3.5 Implantable Infusion Pumps
        8.1.3.6 Patient-Controlled Analgesia Infusion Pumps
    8.2 Accessories/ Consumables
        8.2.1 Dedicated Disposables
            8.2.1.1 Volumetric Pump Disposables
            8.2.1.2 Syringe Pump Disposables
            8.2.1.3 Ambulatory Pump Disposables
            8.2.1.4 Enteral Pump Disposables
            8.2.1.5 Insulin Pump Disposables
            8.2.1.6 Implantable Pump Disposables
            8.2.1.7 Patient-Controlled Analgesia Pump Disposables
        8.2.2 Non-Dedicated Disposables
            8.2.2.1 Infusion Catheters
            8.2.2.2 IV Sets
            8.2.2.3 Cannulas
            8.2.2.4 Tubing
            8.2.2.5 Needles
            8.2.2.6 Valves
9. Infusion Pump Market – By Application(Market Size –$Million/$Billion)
    9.1 Hematological Disorders
    9.2 Cancer
    9.3 Gastroenterological Disorders
    9.4 Analgesia/Pain Management
    9.5 Diabetes
    9.6 Pediatrics/Neonatal Disorders
10. Infusion Pump Market – By End-Use (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Ambulatory Surgery Centers
    10.3 Home Care
    10.4 Others
11. Infusion Pump Market - By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia-Pacific
        11.3.1.1 China
        11.3.1.2 Japan
        11.3.1.3 South Korea
        11.3.1.4 India
        11.3.1.5 Australia & New Zealand
        11.3.1.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Infusion Pump Market - Entropy
13. Infusion Pump Market – Industry/Segment Competition Landscape  (Premium) 
    13.1. Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Country- Key companies
        13.1.4 Best Practices for Companies
14. Infusion Pump Market – Key Company List by Country Premium (Premium)
15. Infusion Pump Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 B.Braun Melsungen AG
    15.3 Baxter International Inc
    15.4 Johnson & Johnson
    15.5 Medtronic PLC
    15.6 Smiths Medical 
    15.7 Roche Diagnostics
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10 and more
*Financials for private companies would be provided on a best efforts basis”.